Skip to content

CGM Academy for Youth With Type 1 Diabetes

Randomized Control Trial Evaluating the Impact of CGM Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 1 Diabetes

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06408207
Enrollment
90
Registered
2024-05-10
Start date
2025-05-01
Completion date
2026-12-30
Last updated
2026-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type1 Diabetes

Keywords

Continuous Glucose Monitoring, Glycemic Control, Diabetes Education, Type1 Diabetes

Brief summary

The goal of this randomized clinical trial is to compare the effects of a virtual education curriculum in blood glucose variation of youth with type 1 diabetes wearing continuous glucose monitoring (CGM) device. The main questions the study aims to answer are: * Do participants undertaking the proposed curriculum present improved glucose variation than participants of standard education? * Explore relationships between participant's glycemic outcomes with diabetes distress, diabetes family responsibilities, and number of hours of diabetes education. Participants in the intervention group will: * receive an interactive workbook with problem-based learning scenarios and video links about CGM and glucose management strategies. * participate in four in-depth online group sessions with diabetes care and education specialists * complete questionnaires three times: at the time of study enrollment, week 4 and 6 months. Participants in the comparison group will: * receive standard education provided to all patients at CHLA * complete questionnaires three times: at the time of study enrollment, week 4 and 6 months.

Detailed description

Youth with type 1 diabetes (T1D) are at increased risk for kidney failure, vision loss, heart disease, and premature mortality due to challenges with glycemic excursions. Continuous glucose monitoring (CGM) systems represent an important advance in diabetes technology with significant advantages over self-monitored blood glucose and the potential to optimize glycemic management. Despite these advances, youth with T1D, including patients at Children's Hospital Los Angeles (CHLA), fail to achieve recommended glycemic targets, highlighting the opportunity for testing innovative diabetes education programs aimed at increased technology uptake such as the CGM Academy intervention.

Interventions

BEHAVIORALCGM Academy

Educational materials as well as online sessions with diabetes educators.

Sponsors

Children's Hospital Los Angeles
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Everyone will know their assigned intervention.

Intervention model description

Simple randomization

Eligibility

Sex/Gender
ALL
Age
8 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Current age of 8-18 years, age group eligible for CGM therapy with Dexcom G6 and G7 * T1D duration ≥6 months, as insulin adjustments during honeymoon stage differs from establishedT1D * Able to speak, read, and write English or Spanish * Smartphone compatible with Dexcom G6 and G7application * Ability to participate in virtual visits

Exclusion criteria

• Known history of medical adhesive allergies

Design outcomes

Primary

MeasureTime frameDescription
Mean change in Hemoglobin A1c from baseline to 6 monthsBaseline to 6 monthsChange in Hemoglobin A1c

Secondary

MeasureTime frameDescription
Mean change in HbA1c (%) from baseline to 6 months.Baseline to 6 monthsChange in Hemoglobin A1c
Mean change in CGM metrics measured by CGM readingsWeek 4 & 6 months% Glucose Time in Range (70-180 mg/dL), % Glucose Time Below Range (\<70mg/dL), % Glucose Time Above Range (\>180mg/dL).
Change in perceived diabetes distress at baseline, week 4 & 6 monthsBaseline, Week 4 & 6 monthsThe Problem Areas in Diabetes survey (PAID) is an 18-item survey to assess the perceived burden associated with diabetes. Youth and caregivers are given statements about diabetes-related issues and report on a 5-point Likert scale (0 = not a problem, 1 = minor problem, 2 = moderate problem, 3 = somewhat serious problem, 4 = serious problem) the degree to which the statements are a problem for them. Increasing scores denote increased burden perceived.
Change in perceived diabetes family responsibility at baseline, week 4 & 6 months.Baseline, week 4 & 6 monthsThe Diabetes Family Responsibility Questionnaire (DFRQ) is a 14-item validated survey assessing parental and child involvement in various diabetes management tasks. Youth and caregivers report on a 3-point scale (1=child, 2=equal, 3=parent) who is responsible for a given diabetes task. Higher scores indicate more parental involvement in diabetes management.
Average number of diabetes educator hours used per study participant at week 4 & 6 months.Week 4 and 6 monthsNumber of hours spent in diabetes education
Perceived benefits of Continuous Glucose Monitor (CGM) useweek 4 & 6 monthsAdolescent Benefits and Burdens of CGM Survey - BenCGM \& BurCGM. Participants answer each question on a scale of Strong Disagree, Disagree, Neutral, Agree, Strongly Agree.
Perceived burden of Continuous Glucose Monitor (CGM) useweek 4 & 6 monthsAdolescent Benefits and Burdens of CGM Survey - BenCGM \& BurCGM. Participants answer each question on a scale of Strong Disagree, Disagree, Neutral, Agree, Strongly Agree.

Countries

United States

Contacts

CONTACTRebecca Barber, PhD, RN
rbarber@chla.usc.edu(323) 361-1359
CONTACTNatalia Garban
ngarban@chla.usc.edu
PRINCIPAL_INVESTIGATORRebecca Barber, PhD, RN

Children's Hospital Los Angeles

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026